Ph.D

Novartis has one of the most   exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Clinical Scientifc Expert - II

Covance is one of the world’s largest and most comprehensive drug development services companies with more than 11,000 employees in 60 countries. Through its nonclinical, clinical and commercialization services, Covance has helped pharmaceutical and biotech companies develop one-third of all prescription medicines in the market today.

Post  : Senior Lead Scientist

Covance is one of the world’s largest and most comprehensive drug development services companies with more than 11,000 employees in 60 countries. Through its nonclinical, clinical and commercialization services, Covance has helped pharmaceutical and biotech companies develop one-third of all prescription medicines in the market today.

Post : Staff Scientist Immunology & Immunotoxicology

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercialises innovative medicines in areas of unmet medical need. With each new discovery and investigational drug candidate, we seek to improve the care of patients living with life-threatening diseases around the world. Gilead’s therapeutic areas of focus include HIV/AIDS, liver diseases, cancer and inflammation, and serious respiratory and cardiovascular conditions.

Post : Senior Medical Scientist Oncology- Northeast

Applications are invited for the post of Research Associate with life sciences background for BIRAC funded project entitled “Preclinical evaluation of Centrin knockout five attenuated Leishmania clinical grade parasite vaccine against visceral leishmaniasis”, under Principal Investigator Dr. Poonam Salotra, JC Bose National Fellow, National Institute of Pathology (ICMR).

About Dibrugarh University
Dibrugarh University was established in 1965 consequent upon the provisions of the Dibrugarh University Act, 1965, enacted by the Assam Legislative Assembly. It is a leading research and innovation driven University that acts as a spatial slot to configure the socio-cultural dynamics of North East India. The University hosts 175 affiliated colleges and institutes that spread over the districts of upper Assam. It is situated at Rajabheta, five kilometres to the South of Dibrugarh town and well connected by road, rails, air and waterways. The University has a vast sprawling campus (550 acres) set in bucolic and idyllic surroundings.

I.I.T. Delhi is an autonomous statutory organisation functioning within the “Institutes of Technology Act” as amended by “The Institutes of Technology (Amendment) Act, 1963″. The seven Indian Institutes of Technology (others being at Bombay, Kanpur, Kharagpur, Madras and Guwahati Roorkee) are administered centrally by the IIT Council, an apex body established by the Government of India to co-ordinate activities of these Institutes. The Minister for Human Resource Development of the Government of India is the Chairman of the Council. Each Institute of Technology has a Board of Governors responsible for its overall administration and control. Mr. Rameshwar Pal Agrawal is the Chairman of the Board of Governors of this Institute.

Candidates of Indian nationality are invited to appear for the Walk-in test / interview for project appointments under the following project. Appointment shall be on contractual basis on consolidated pay renewable yearly or upto the duration of the project, whichever is earlier.

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

Post : Diabetes Care Specialist

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

Post : Director- Clinical Development & Research